secwatch.observer — SEC 8-K summary
======================================

Issuer:     Minerva Neurosciences, Inc. (NERV)
CIK:        0001598646
Form:       8-K
Filed at:   2025-12-22T23:59:59+00:00
Accession:  0001193125-25-328715
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Minerva Neurosciences stockholders approve increase in authorized common shares to 250M and 12.5M new equity plan shares
--------------------------------------------------------------------------------

- Stockholders approved increasing authorized common shares from 125M to 250M. Votes: 4,917,181 for, 314,773 against.
- Approved amendment to 2013 Equity Plan adding 12,500,000 shares for issuance under the plan. Votes: 3,653,490 for, 32,045 against.
- Elected Fouzia Laghrissi-Thode and Inderjit Kaul as directors with 3,502,340 and 3,650,817 votes for, respectively.
- Approved issuance of common shares upon conversion of Series A Preferred Stock. Votes: 2,909,574 for, 114,818 against.
- Ratified Deloitte & Touche as independent auditor for FY2025 with 5,152,013 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1598646/000119312525328715/0001193125-25-328715-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1598646/000119312525328715/d16725d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-328715

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer